Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.0%

11 terminated/withdrawn out of 92 trials

Success Rate

82.8%

-3.7% vs industry average

Late-Stage Pipeline

14%

13 trials in Phase 3/4

Results Transparency

40%

21 of 53 completed trials have results

Key Signals

14 recruiting21 with results9 terminated

Enrollment Performance

Analytics

Phase 1
23(33.8%)
Phase 2
20(29.4%)
N/A
12(17.6%)
Phase 3
11(16.2%)
Phase 4
2(2.9%)
68Total
Phase 1(23)
Phase 2(20)
N/A(12)
Phase 3(11)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (92)

Showing 20 of 92 trials
NCT07430306Phase 3Recruiting

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

Role: collaborator

NCT06465810Recruiting

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

Role: collaborator

NCT07205666Recruiting

The Eplontersen Pregnancy and Lactation Outcomes Study

Role: collaborator

NCT04844866Phase 2Recruiting

Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients

Role: collaborator

NCT04883333Phase 1Completed

A Single and Multiple Ascending-dose Trial of LEO 153339 in Healthy Adults

Role: collaborator

NCT07199569Phase 2Active Not Recruiting

Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells

Role: collaborator

NCT05361486Completed

Radical Cure (RC) With Tafenoquine or Primaquine After Semi-quantitative G6PD Testing: A Feasibility Study in Peru

Role: collaborator

NCT06941025Recruiting

Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding

Role: collaborator

NCT06328608Phase 2Recruiting

A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease

Role: collaborator

NCT05710692Phase 2Recruiting

Study to Evaluate the Safety, PK, PD, and Efficacy of PRX-102 in Japanese Patients With Fabry Disease

Role: collaborator

NCT07059000Phase 3Recruiting

A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)

Role: collaborator

NCT06564974Recruiting

Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT

Role: collaborator

NCT03513939Phase 1Active Not Recruiting

A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation

Role: collaborator

NCT05997264Phase 2Active Not Recruiting

Anthrax AV7909 Boost Evaluation Study

Role: collaborator

NCT04620239Phase 3Recruiting

ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study

Role: collaborator

NCT07076030Phase 1Completed

Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal Function

Role: collaborator

NCT06560151Phase 2Completed

Assess Safety and Immunogenicity of A/H5 Inactivated Monovalent Influenza Vaccines at Different Antigen Dose Levels Adjuvanted With AS03 or MF59

Role: collaborator

NCT06252753Recruiting

Observational Study Protocol: LIVER-R

Role: collaborator

NCT05979207Phase 1Completed

Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. Falciparum

Role: collaborator

NCT06716606Phase 3Recruiting

A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)

Role: collaborator